Jimmy Fund Press Releases

2018

Dana-Farber/Brigham and Women's Cancer Center recognized as the best in the region, and among the nation’s best, for 18th consecutive year
August 14, 2018

Dana-Farber/Brigham and Women's Cancer Center recognized as the best in the region, and among the nation’s best, for 18th consecutive year

Dana-Farber/Boston Children's again ranked among the top national pediatric cancer programs
June 26, 2018

U.S. News & World Report has ranked Dana-Farber/Boston Children's Cancer and Blood Disorders Center the top pediatric cancer program in New England and #3 in the nation.

Dana-Farber/Brigham and Women’s Cancer Center offers CAR T-cell therapy Kymriah™, now approved for lymphoma
May 01, 2018

Dana-Farber is a certified treatment center for the just approved CAR T-cell therapy, tisagenlecleucel (Kymriah™) for certain lymphoma patients.

Patients and researchers team up to fight metastatic prostate cancer
February 26, 2018

Researchers launched the Metastatic Prostate Cancer Project (MPC), a patient-partnered initiative that encourages men with metastatic prostate cancer across the U.S. and Canada to collaborate.

Sign up for updates ›